LifeCycle Pharma A/S - Report Pursuant to the Danish Securities Trading Act, Section 28(a)
26-05-10 kl. 26/5 2010 22:50 | Veloxis Pharmaceuticals 0,90 (+4,65%)
Se flere nyheder om Veloxis Pharmaceuticals
Company Announcement no. 9/2010
To: NASDAQ OMX Copenhagen Hørsholm, Denmark, May 26, 2010
LifeCycle Pharma A/S - Report Pursuant to the Danish Securities Trading Act,
Section 28(a)
Hørsholm, Denmark, May 26, 2010; Pursuant to the Danish Securities Trading Act,
Section 28(a), LifeCycle Pharma A/S (OMX: LCP) is required on a daily basis, to
make public transactions in LifeCycle Pharma shares and related securities by
persons discharging managerial responsibilities and persons / companies closely
associated with these.
Name KAN ApS (100% owned by Kurt Anker Nielsen)
Reason for reporting Member of the Board of Directors
Issuer and ID code/ISIN LifeCycle Pharma A/S / DK0060048148
Type of transaction Purchase of shares
Date of transaction May 26, 2010
Relevant market NASDAQ OMX Copenhagen
Number of traded securities 23,000
Market value DKK 101,200
For more information, please contact:
LifeCycle Pharma A/S
Peter Schøtt Knudsen
Head of Investor Relations
Phone: + 45 2055 3817
Email: [email protected]
26 may 2010 - lifecycle pharma - report pursuant to the danish securities trading act section 28_a_.tif
Skriv en kommentarer til denne artikel:
Send kommentar
| PRIS | 0,90 |
|---|---|
| ÆNDRING | +0,04 (+4,65%) |
| ÅBEN | 0,87 |
| SIDSTE LUK | 0,86 |
| DEBAT | - |
 |
